Michael Scharl

25.0k total citations · 1 hit paper
245 papers, 7.1k citations indexed

About

Michael Scharl is a scholar working on Genetics, Molecular Biology and Surgery. According to data from OpenAlex, Michael Scharl has authored 245 papers receiving a total of 7.1k indexed citations (citations by other indexed papers that have themselves been cited), including 113 papers in Genetics, 101 papers in Molecular Biology and 81 papers in Surgery. Recurrent topics in Michael Scharl's work include Inflammatory Bowel Disease (90 papers), Microscopic Colitis (56 papers) and Protein Tyrosine Phosphatases (38 papers). Michael Scharl is often cited by papers focused on Inflammatory Bowel Disease (90 papers), Microscopic Colitis (56 papers) and Protein Tyrosine Phosphatases (38 papers). Michael Scharl collaborates with scholars based in Switzerland, United States and Germany. Michael Scharl's co-authors include Gerhard Rogler, Stephan R. Vavricka, Marianne R. Spalinger, Luc Biedermann, Silvia Lang, Michael Fried, Declan F. McCole, Pascal Frei, Alain Schoepfer and Alexander A. Navarini and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and Journal of Clinical Oncology.

In The Last Decade

Michael Scharl

231 papers receiving 7.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Extraintestinal Manifestations of Inflammatory Bowel Disease

2015 515 citations Stephan R. Vavricka, Alain Schoepfer et al. Inflammatory Bowel Diseases profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Michael Scharl Switzerland	45	2.8k	2.7k	1.9k	1.7k	1.5k	245	7.1k
Katsuyoshi Matsuoka Japan	41	1.9k 0.7×	2.3k 0.8×	1.5k 0.8×	1.2k 0.7×	1.5k 1.0×	206	5.8k
Shigeki Bamba Japan	38	2.5k 0.9×	1.9k 0.7×	1.1k 0.6×	1.3k 0.8×	1.4k 1.0×	146	6.2k
Hiroshi Nakase Japan	48	2.4k 0.8×	2.1k 0.8×	2.2k 1.2×	2.4k 1.4×	1.9k 1.3×	391	8.7k
R. D’Incà Italy	49	1.6k 0.6×	3.6k 1.3×	2.5k 1.3×	2.1k 1.2×	1.2k 0.8×	229	7.5k
Sebastian Zeißig Germany	31	3.8k 1.3×	2.0k 0.7×	1.5k 0.8×	1.5k 0.9×	2.6k 1.8×	87	8.6k
Clara Abraham United States	40	2.5k 0.9×	2.8k 1.1×	1.5k 0.8×	1.4k 0.8×	3.6k 2.5×	82	8.0k
Hai Yun Shi China	20	1.7k 0.6×	3.4k 1.2×	2.0k 1.1×	1.5k 0.9×	794 0.5×	43	5.6k
Zhanju Liu China	45	4.1k 1.5×	2.0k 0.7×	1.1k 0.6×	1.3k 0.7×	2.6k 1.8×	172	8.3k
Torsten Kucharzik Germany	50	1.8k 0.6×	3.7k 1.4×	2.6k 1.4×	2.5k 1.5×	2.6k 1.8×	198	9.2k
Laurent Dubuquoy France	40	2.6k 0.9×	1.4k 0.5×	1.3k 0.7×	1.1k 0.7×	1.1k 0.7×	104	6.1k

Countries citing papers authored by Michael Scharl

Since Specialization

Citations

This map shows the geographic impact of Michael Scharl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Scharl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Scharl more than expected).

Fields of papers citing papers by Michael Scharl

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Scharl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Scharl. The network helps show where Michael Scharl may publish in the future.

Co-authorship network of co-authors of Michael Scharl

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Scharl. A scholar is included among the top collaborators of Michael Scharl based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Scharl. Michael Scharl is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Morsy, Yasser, Patrick Turko, Marjam J. Barysch, et al.. (2025). The serum metabolome serves as a diagnostic biomarker and discriminates patients with melanoma from healthy individuals. Cell Reports Medicine. 6(8). 102283–102283.

Losa, Marco, Marlene Schwarzfischer, Marc Emmenegger, et al.. (2025). Unraveling the Converging Roles of ASC-Dependent Inflammasomes, Interleukin-1 Superfamily Members, Serum Amyloid A, and Non-Sterile Inflammation in Disease Pathology and Fibrosis in Inflammatory Bowel Disease and Primary Sclerosing Cholangitis. International Journal of Molecular Sciences. 26(16). 8042–8042. 1 indexed citations

Schneider, Marcel, Ralph Fritsch, Daniel Pohl, et al.. (2024). Detection rate of colorectal cancer by routine colonoscopy is comparable in patients aged 45–49 and 50–54 years. Swiss Medical Weekly. 154(7). 3769–3769.

Schwarzfischer, Marlene, Sung Sik Lee, Marcin Wawrzyniak, et al.. (2024). Impact of Nanoplastic Particles on Macrophage Inflammation and Intestinal Health in a Mouse Model of Inflammatory Bowel Disease. Nanomaterials. 14(16). 1350–1350. 5 indexed citations

Morsy, Yasser, Céline Mamie, Alain Schoepfer, et al.. (2024). Novel transcriptomic panel identifies histologically active eosinophilic oesophagitis. Gut. 73(7). 1076–1086. 3 indexed citations

Morsy, Yasser, Michael Scharl, Jan H. Rüschoff, et al.. (2024). Towards Reliable Methodology: Microbiome Analysis of Fresh Frozen vs. Formalin-Fixed Paraffin-Embedded Bladder Tissue Samples: A Feasibility Study. Microorganisms. 12(12). 2594–2594. 1 indexed citations

Spalinger, Marianne R. & Michael Scharl. (2023). Microbiota Manipulation as an Emerging Concept in Cancer Therapy. Visceral Medicine. 40(1). 2–11. 2 indexed citations

Honcharova‐Biletska, Hanna, Daniel Segna, Klaus Steigmiller, et al.. (2023). Performance of two‐dimensional shear wave elastography and transient elastography compared to liver biopsy for staging of liver fibrosis. European Journal of Clinical Investigation. 53(7). e13980–e13980. 8 indexed citations

Wawrzyniak, Paulina, Marcin Wawrzyniak, Sylvie Scharl, et al.. (2023). Crosstalk within peripheral blood mononuclear cells mediates anti-inflammatory effects of n-3 PUFA-rich lipid emulsions in parenteral nutrition. Clinical Nutrition. 42(12). 2422–2433. 2 indexed citations

10.

Vallière, Cheryl de, Jesús Cosín‐Roger, Katharina Baebler, et al.. (2022). pH-Sensing G Protein-Coupled Receptor OGR1 (GPR68) Expression and Activation Increases in Intestinal Inflammation and Fibrosis. International Journal of Molecular Sciences. 23(3). 1419–1419. 20 indexed citations

11.

Hering, Larissa, Marlene Schwarzfischer, Marcin Wawrzyniak, et al.. (2021). Macrophages Compensate for Loss of Protein Tyrosine Phosphatase N2 in Dendritic Cells to Protect from Elevated Colitis. International Journal of Molecular Sciences. 22(13). 6820–6820. 4 indexed citations

12.

Rogler, Gerhard, Michael Scharl, Marianne R. Spalinger, et al.. (2021). Diet and Inflammatory Bowel Disease: What Quality Standards Should Be Applied in Clinical and Laboratory Studies?. Molecular Nutrition & Food Research. 65(5). e2000514–e2000514. 3 indexed citations

13.

Juillerat, Pascal, Andreas E. Kremer, Gerhard Rogler, et al.. (2021). Modulation of the Mucosa-Associated Microbiome Linked to the PTPN2 Risk Gene in Patients with Primary Sclerosing Cholangitis and Ulcerative Colitis. Microorganisms. 9(8). 1752–1752. 5 indexed citations

14.

Conde, Javier, et al.. (2021). Titanium Dioxide Presents a Different Profile in Dextran Sodium Sulphate-Induced Experimental Colitis in Mice Lacking the IBD Risk Gene Ptpn2 in Myeloid Cells. International Journal of Molecular Sciences. 22(2). 772–772.

15.

Schwarzfischer, Marlene, Kirstin Atrott, Andrea Laimbacher, et al.. (2021). Combination of Vedolizumab With Tacrolimus Is More Efficient Than Vedolizumab Alone in the Treatment of Experimental Colitis. Inflammatory Bowel Diseases. 27(12). 1986–1998. 5 indexed citations

16.

Morell, Bernhard, Philipp K. Buehler, Patrick R. Bader, et al.. (2021). Efficient treatment of esophageal nutrition bezoars: dissolution outmatches removal—the Zurich approach. Clinical Journal of Gastroenterology. 14(6). 1602–1606. 2 indexed citations

17.

Lucchinetti, Eliana, Phing‐How Lou, Paulina Wawrzyniak, et al.. (2020). Novel Strategies to Prevent Total Parenteral Nutrition‐Induced Gut and Liver Inflammation, and Adverse Metabolic Outcomes. Molecular Nutrition & Food Research. 65(5). e1901270–e1901270. 18 indexed citations

18.

Lou, Phing‐How, Eliana Lucchinetti, Paulina Wawrzyniak, et al.. (2020). Choice of Lipid Emulsion Determines Inflammation of the Gut‐Liver Axis, Incretin Profile, and Insulin Signaling in a Murine Model of Total Parenteral Nutrition. Molecular Nutrition & Food Research. 65(5). e2000412–e2000412. 9 indexed citations

19.

Schreiner, Philipp, Bahtiyar Yılmaz, Jean‐Benoît Rossel, et al.. (2019). Vegetarian or gluten‐free diets in patients with inflammatory bowel disease are associated with lower psychological well‐being and a different gut microbiota, but no beneficial effects on the course of the disease. United European Gastroenterology Journal. 7(6). 767–781. 74 indexed citations

20.

Scharl, Sylvie, Stephan R. Vavricka, Gerhard Rogler, et al.. (2019). Association of IBD specific treatment and prevalence of pain in the Swiss IBD cohort study. PLoS ONE. 14(4). e0215738–e0215738. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact